5-amino-1mq nnmt inhibitor study obesity — 50mg | (NAD+ Axis) Longevity, Performance & Obesity Capsules

Anyone pregnant, breastfeeding, or with a diagnosed metabolic, hepatic, or endocrine condition falls entirely outside any studied context and should not be a subject of self-directed use

Best published PK (Awosemo et al., 2021, rats): ~38% oral bioavailability, ~6 to 7 hr oral half-life

Some people report feeling improvements in energy, recovery, and overall vitalitywith guidance from Elases network of licensed medical providers

The main difference is that AHK-Cu is a synthetic copper peptide

Someone who struggles with hunger and cravings may find compounds like cagrilintide or semaglutide more helpful than 5-amino-1mq alone